Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Matsuda

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 11, 2025
Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle Array patch deliveryMadison M Driskill, Ian A Coates, Paul J Hurst, et al.
Immunity|September 20, 2014
Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cellsNina Calantone, Fan Wu, Zachary Klase, et al.
Journal of Virology|April 22, 2024
A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primatesDaniel Thoresen, Kenta Matsuda, Akane Urakami, et al.
Nature Communications|May 19, 2023
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concernMai Komori, Takuto Nogimori, Amber L Morey, et al.
Cell Reports. Medicine|August 16, 2023
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 studyWataru Akahata, Takashi Sekida, Takuto Nogimori, et al.
Science Translational Medicine|November 12, 2025
Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccineWataru Akahata, Mai Komori, Amber L Morey, et al.
Nature Medicine|January 20, 2015
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllersYoshinori Fukazawa, Richard Lum, Afam A Okoye, et al.
The Journal of Clinical Investigation|February 2, 2021
A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunityKenta Matsuda, Stephen A Migueles, Jinghe Huang, et al.
Nature Medicine|March 22, 2016
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesAnn J Hessell, J Pablo Jaworski, Erin Epson, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular VaccinesBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 11, 2025
Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle Array patch deliveryMadison M Driskill, Ian A Coates, Paul J Hurst, et al.
Immunity|September 20, 2014
Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cellsNina Calantone, Fan Wu, Zachary Klase, et al.
Journal of Virology|April 22, 2024
A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primatesDaniel Thoresen, Kenta Matsuda, Akane Urakami, et al.
Nature Communications|May 19, 2023
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concernMai Komori, Takuto Nogimori, Amber L Morey, et al.
Cell Reports. Medicine|August 16, 2023
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 studyWataru Akahata, Takashi Sekida, Takuto Nogimori, et al.
Science Translational Medicine|November 12, 2025
Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccineWataru Akahata, Mai Komori, Amber L Morey, et al.
Nature Medicine|January 20, 2015
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllersYoshinori Fukazawa, Richard Lum, Afam A Okoye, et al.
The Journal of Clinical Investigation|February 2, 2021
A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunityKenta Matsuda, Stephen A Migueles, Jinghe Huang, et al.
Nature Medicine|March 22, 2016
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesAnn J Hessell, J Pablo Jaworski, Erin Epson, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular VaccinesBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Pageof 6